Health-care food for delaying senility and regulating blood fat, and its production

A technology for regulating blood lipids and health food, applied in the field of production technology of the health food, can solve the problems of inconvenient eating and carrying, poor stability of lecithin, bad taste and other problems, and achieve easy absorption, low production cost, and prevent air and the effect of moisture penetration

Active Publication Date: 2005-12-28
JIANGZHONG PHARMA
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented technology allows for an improved way to make certain types of products that contain lecysteine or other substances like caffeoyl alcohol (CAS) without losing their original quality. These improvements result from reducing the amount of material used while maintaining its stability during storage. Additionally, they allow users to easily take them when eaten on breads instead of cooked rice because these ingredients release odors over time rather than just being absorbed into our body' s digestive system. Overall, this innovative process improves both usability and flavor retention capabilities compared to existing methods such as adding extra materials or modifying processes.

Problems solved by technology

This patented technical problem addressed in this patents relates to finding ways to improve the quality of life due to increased risk factors associated with obstructive sleep apnea syndrome such as hypertension, diabetes mellitis, stroke, depression, neurological disease, cancer, Parkinson' s Dementia, etc., through nutritional drink compositions containing specific types of carboxylate compounds called lycothlinum extract(LLC), hydroxyproline plasma solution/liquidexaponase solvent extraction system, polygalactoannery powder, lycopene gelatin, polyunsaturated linseed oil, probiobium collagen, citranoserlipid, calcium salt, magnesite, copper sulphochlorophyll salts, urolithin beta glucuronosis, selenium enzyme, cyclohexaselenostimulators, and various sugurs derived from natural sources like milk proteins, fats, yeast protein fractions, and berries. These active agents have potential benefits on prevention and treatment of arterial stenosis caused by excessively high levels of serum total cholate (TSC).

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] 200 parts of soybean lecithin, 20 parts of vitamin E, 120 parts of calcium carbonate, 600 parts of sucrose powder, 20 parts of micronized silica gel, 20 parts of magnesium stearate, 20 parts of hydroxypropyl methylcellulose.

[0043] Production process: Take soy lecithin, vitamin E, calcium carbonate, sucrose powder and other raw materials in proportion and mix them evenly, add 3 times the appropriate amount of distilled water to make soft material, pass through 14 mesh sieve to granulate, dry at 65 ℃, 16 mesh sieve Add micro-powdered silica gel and magnesium stearate to mix well, and press the 21-stroke rotary tablet machine into a plain tablet with a weight of 0.98 grams, and then pack the compressed plain tablet with a hydroxypropyl methylcellulose coating material The weight of each piece is increased to 1 gram by dressing, and the finished product is obtained.

Embodiment 2

[0045] 50 parts of soybean lecithin, 5 parts of vitamin E, 50 parts of calcium carbonate, 65 parts of calcium phosphate, 145 parts of sucrose powder, 200 parts of lactose powder, 10 parts of micronized silica gel, 15 parts of magnesium stearate, 10 parts of hydroxypropyl methylcellulose Servings, production process: take soy lecithin, vitamin E, calcium carbonate, calcium phosphate, sucrose powder, lactose powder and other raw materials in proportion, mix them evenly, add 1 times the appropriate amount of distilled water to make soft material, and pass through 14 mesh sieve to granulate. Dry at ℃, 16-mesh sieve into granules, add micro-powder silica gel and magnesium stearate and mix well, and press it into a 21-stroke rotary tablet press. The weight of each tablet is controlled to 0.485 g. After coating, the weight of the finished tablet is 0.5 g per tablet. .

Embodiment 3

[0047] 500 parts of soybean lecithin, 50 parts of vitamin E, 400 parts of calcium carbonate, 300 parts of lactose powder, 50 parts of sucrose powder, 30 parts of micronized silica gel, 30 parts of magnesium stearate, 30 parts of hydroxypropyl methylcellulose. Production process: Take soy lecithin, vitamin E, calcium carbonate, sucrose powder, lactose powder and other raw materials in proportion, mix them evenly, add 5 times the appropriate amount of distilled water to make soft material, pass through 14 mesh sieve to granulate, dry at 65℃, 16 The granules are sieved through a mesh, mixed with finely powdered silica gel and magnesium stearate, and compressed into a 21-stroke rotary tablet press. The weight of each tablet is controlled to 0.98 grams. After coating, the weight of the finished tablet is 1 gram per tablet.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A health-care food for delaying senility and regulating blood fat is prepared from lecithin, VE and the excipient prepared from calcium carbonate, calcium phosphate, cane sugar powder, lactose powder, sorbitol, gelatin, micropowdered silica gel, magnesium stearate and hydroxypropyl methylcellulose.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner JIANGZHONG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products